Article citationsMore>>
Otto, C.M., Nishimura, R.A., Bonow, R.O., Carabello, B.A., Erwin, J.P., Gentile, F., Jneid, H., Krieger, E.V., Mack, M., McLeod, C., O’Gara, P.T., Rigolin, V.H., Sundt, T.M., Thompson, A. and Toly, C. (2021) 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology, 77, e25-e197.
https://doi.org/10.1016/j.jacc.2020.11.035
has been cited by the following article:
-
TITLE:
Transcatheter Aortic Valve Replacement in High-Risk Surgical Patient with Severe Aortic Insufficiency
AUTHORS:
Farid Khan, Danielle Cannon, Alon Yarkoni
KEYWORDS:
TAVR, Aortic Insufficiency, Aortic Sclerosis, Congestive Heart Failure, Infective Endocarditis
JOURNAL NAME:
World Journal of Cardiovascular Diseases,
Vol.12 No.7,
July
18,
2022
ABSTRACT: Background:Transcatheter aortic valve replacement (TAVR) is approved by the FDA for severe aortic stenosis (AS) in patients of all surgical risk categories but has yet to be studied for its utility in aortic insufficiency (AI), despite the need for a safe alternative to surgery for prohibitive surgical risk patients. Case Report: We describe a case of a female patient who presented with acute decompensated congestive heart failure (CHF) with New York Heart Association (NYHA) Class IV symptoms. She was found to have severe AI leading to acute decompensation. Two years prior to this, she had aortic valve endocarditis that had potentially resulted in severe AI. Considering her underling comorbidities including diabetes mellitus, hypertension, morbid obesity and multiple myeloma on active chemotherapy at the time of evaluation, the patient was a high-risk surgical candidate for surgical aortic valve repair (SAVR)in view of elevated risk of mortality, infection, and poor wound healing. After critical and comprehensive assessment, transcatheter aortic valve intervention was considered to be an appropriate choice of treatment. TAVR was successfully performed that resulted in immediate improvement of aortic valve function. On subsequent follow-ups, she demonstrated markedly improved symptoms and reduced status to NYHA Class II HF symptoms. Conclusion: TAVRis a potential treatment modality for patients with severe AI who are poor surgical candidates for SAVR. We hope our case contributes to the growing pool of studies investigating the utility of TAVR procedure in patients with severe AI.
Related Articles:
-
Debora Brala, Thomas G. Allison, Wilhelm Haverkamp, Ingolf Schimke, Olaf Schulz
-
John Pham, Stephen Nageotte, Jon Detterich, Grace Kung
-
Diallo Hassatou, Camara Ousmane Mamadama, Keita Fatoumata Binta, Barry Mamadou, Touré Abdoulaye Fodé, Diallo Salematou, Mahman Roufai Ogoukoya, Kaba Abdoul Karim, Barry Alpha, Kpoulomou Francis, Diallo Souleymane M’Bara, Baldé Elhadj Yaya, Barry Ibrahima Sory, Beavogui Mariame, Baldé Mamadou Dadhi
-
Abdulrahman Alsheikh, Ahmed Aljedai, Hajer Almudaiheem, Salwa Alaidarous, Ali Alshehri, Hussein Elbadawi, Saeed Alghamdi, Faisal Aljehani, Sami Alobaidi, Talal A. Altuwaijri, Khalid Almatham, Saud Alsifri, Emad R. Issak
-
Awa Ba-Diop, Abdou Khadir Sow, Rim Mohamed Khaled, Mor Diaw, Mame Saloum Coly, Fulgence Abdou Faye, Amadou Ndiadé, Bamba Gaye, Abdoulaye Ba, Abdoulaye Samb